Skip to search formSkip to main contentSkip to account menu

manumycin

Known as: 2,4-Decadienamide, N-(5-hydroxy-5-(7-((2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino)-7-oxo-1,3,5-heptatrienyl)-2-oxo-7-oxabicyclo(4.1.0)hept-3-en-3-yl)-2,4,6-trimethyl-, UCFI-C, manumycin a 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
ABSTRACT It is now becoming well established that vesicles are released from a broad range of cell types and are involved in cell… 
Highly Cited
2013
Highly Cited
2013
Therapy resistance can be attributed to acquisition of anti-apoptotic mechanisms by the cancer cells. Therefore, developing… 
Highly Cited
2001
Highly Cited
2001
Our laboratory has investigated the anticancer effects of combined manumycin (a farnesyltransferase inhibitor) and paclitaxel (a… 
Highly Cited
2001
Highly Cited
2001
This report describes 2 patients with a clinical and hematologic diagnosis of chronic myeloid leukemia (CML) in chronic phase who… 
Highly Cited
2000
Highly Cited
2000
Despite the current multimodal approach to treatment of anaplastic thyroid cancer (ATC), the prognosis for patients with the… 
1987
1987
Manumycin (1), produced by Streptomyces parvulus (strain Tu 64), was isolated from the mycelium by extraction with acetone and…